Compound library / Cardiovascular
Investigational dual natriuretic peptide receptor (NPR-A/NPR-B) agonist being studied for heart failure.
| Category | Cardiovascular |
|---|---|
| Typical route | Intramuscular |
| Half-life | Not firmly established in humans |
| Common dose range | Trial dosing only — not commercially available |
| Typical cycle length | Not established outside trials |
BioHack Track models Cenderitide at a half-life of 0.5 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Not commercially available outside clinical trials.
N/A — investigational.
Still investigational, hospital/IV-context drug if approved; not relevant to self-administered or grey-market use. Included for reference completeness only.
Track Cenderitide in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Cenderitide — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.